| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.1M | -61.3% |
| R&D Expense | $27.3M | +14.7% |
| SG&A Expense | $63.0M | +26.1% |
| Operating Income | -$85.8M | -41.0% |
| Interest Expense | $5.2M | +95.4% |
| Pre-tax Income | -$67.5M | -87.8% |
| Income Tax | -$4.7M | -52.2% |
| Net Income | -$62.8M | -91.1% |
| EPS (Basic) | -$1.47 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.8M | -56.2% |
| Short-term Investments | $27.7M | — |
| Accounts Receivable | $2.1M | +144.0% |
| Inventory | $899K | +94.2% |
| Current Assets | $79.1M | -27.7% |
| Total Assets | $87.8M | -26.7% |
| Current Liabilities | $17.6M | +29.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.9M | -46.4% |
| Investing Cash Flow | -$27.4M | -2236.9% |
| Financing Cash Flow | $48.6M | -27.6% |
| -17.6% |
| EPS (Diluted) | -$1.47 | -17.6% |
| Long-term Debt |
| $34.4M |
| +19.6% |
| Total Liabilities | $84.6M | +7.6% |
| Stockholders' Equity | $3.2M | -92.2% |